The series is stated in the current share scale after splits; dividends are not included in the price
McKesson distributes medicines to pharmacies and hospitals — enormous turnover at a very thin margin.
A distributor stands between manufacturer and pharmacy and earns small fractions of a per cent on each pack. At those margins profit is set not by price but by logistics: warehouses, routes, inventory turns and demand forecasting accuracy. An error in any of those consumes the entire margin.
The market is split among three distributors, which makes it durable: a new entrant cannot build a comparable warehouse network, and manufacturers will not deliver themselves. Additional, higher-margin income comes from services to oncology clinics and from working with manufacturers on product launches.
A specific factor is opioid litigation settlements: payments are spread over years and recognised in the accounts. Separately significant are high-cost medicines, where the shipment value is large but the percentage the same. McKesson pays a small dividend and buys back stock actively.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
McKesson Corporation (MCK) is a company in the Health care sector; its shares trade on NYSE.
The price of McKesson Corporation (MCK) on November 2, 2026 is 999.29 $, +0.47 % on the day. Over 52 weeks the stock traded between 723.68 $ and 1,003.21 $; the price now sits 99 % of the way up that range. Over the past year the price changed by +26.10 %. The P/E ratio is 25.07, which is close to the sector median (24.61). Market capitalization is 115.12 billion $, rank 1 among 7 stocks of the same industry with a known capitalization.
McKesson Corporation trades on NYSE under the ticker MCK. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks MCK has traded between 723.68 $ and 1,003.21 $. As of 2 November 2026 the price stood 98.37 % of the way from the 52-week low to the high.
Over one year MCK shares rose 26.10 %; over six months they rose 15.14 %. Volatility over 90 days is 30.02 %. Dividends are not included: this is price change only, as of 2 November 2026.
MCK trades at a price-to-earnings ratio of 25.1, above the sector median of 24.6. Price to sales is 0.3, below the sector median of 3.6. Calculated from reports for the period ending 30 June 2026.
McKesson Corporation reported revenue of 411.0B $ and net income of 4.6B $ over the last four quarters. Net margin is 1.12 %. Revenue changed by +8.84 % year over year. Earnings per share are 37.28 $. Market capitalisation is 115.1B $.
